EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 13 April 2023

Blog

Supporting the Head and Neck Cancer Community
13 April 2023

April is Head & Neck Cancer Awareness Month, a chance for all of us to bring attention and resources to these deadly... Read more

Join our team

Senior Manager, Regulatory, Drug development & Manufacturing

The Senior Manager Regulatory, Drug Development & Manufacturing coordinates activities related to regulatory and development topics, including development of policies and position papers, implementation of multi-stakeholder projects, interactions with regulatory authorities (European Medicines Agency, national regulators, European Commission) and support on regulatory matters to other teams at EFPIA. He/She reports to the Director Regulatory Strategy.

For more information on the vacancy, please visit our dedicated page here.

Events

TOPRA Innovation Summit 2023
19 April 2023 (Amsterdam)

Innovation Driving Change Read more

Strengthening European health systems
24 April 2023 (Online)

How to invest in innovation while driving efficiencies. Read more

Realising the potential of the European Health Data Space for Innovation
30 May 2023 (Residence Palace, Rue de la Loi 155, 1040 Brussels)

EFPIA and COPAC are pleased to invite you to an in-person discussion on the key issues that are fundamental in ensuring... Read more

How the pharmaceutical industry is working to avoid and replace the use of animals for scientific...
22 June 2023 (Zoom)

An online event co-organised by EFPIA and the RSPCA Read more

We published

Enhancing patient centric outcome measures and clinical trials with digital health technologies...
13 April 2023 (Publications)

Can digital technology really help to measure meaningful endpoints in clinical trials? Read more

Regulatory Road to Innovation Experts' Insights
22 March 2023 (Publications)

How can we work together to create a world-class 21st century regulatory framework to deliver safer, better medicines... Read more

What we are reading

Sex, gender, and the cost of neurological disorders
On 01 May 2023 (The Lancet)

A white paper entitled Sex, Gender, and the Brain: Towards an Inclusive Research Agenda, published by the Women’s Brain... Read more

Three things will enable society to thrive in the 21st century
On 12 April 2023 (LinkedIn)

In her annual letter for the Merck Sustainability Report, the company's CEO outlines the three things that she believes... Read more

Eli Lilly warns EU will miss out on key drugs under planned change to patent rules
On 10 April 2023 (Financial Times)

Following a briefing by Nathalie Moll to the FT, EFPIA worked with Lilly to secure an interview on the impact of the... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu